Inotek
Pharmaceuticals' Novel Glaucoma Candidate, INO-8875, Significantly Reduces Intraocular Pressure in Phase 1/2 Study -- INO-8875 represents new mechanism of action to treat glaucoma by targeting the trabecular meshwork -- Press Release Source: Inotek Pharmaceuticals On Thursday June 25, 2009, 8:35 am EDT Buzz up! 0 Print.LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals today ...